Status:

COMPLETED

Effect of Transcranial Pulse Stimulation on ADHD

Lead Sponsor:

The Hong Kong Polytechnic University

Conditions:

ADHD

Eligibility:

All Genders

12-17 years

Phase:

NA

Brief Summary

This is the first nationwide study using Transcranial Pulse Stimulation to evaluate its efficacy and safety on 30 young adolescents with ADHD. Six verum/ shamTPS sessions will be delivered to all subj...

Detailed Description

Objectives of the study 1. To evaluate the efficacy and safety of TPS on young adolescents (12-17 years) with ADHD in Hong Kong. 2. To examine the association between TPS and ADHD core symptom severi...

Eligibility Criteria

Inclusion

  • have a confirmed diagnosis of ADHD according to the 5th edition of Diagnostic and Statistical Manual of Mental Disorders (DSM-5) of the American Psychiatric Association;
  • ethic Chinese, aged 12-17, with no co-morbidity of other mental disorders (e.g., Intellectual Disability Disorder) and organic brain diseases that affected cognitive functions;
  • no severe systemic diseases including heart, liver, lung, and kidney diseases;
  • have an IQ \>80 by Stanford-Binet Intelligence Scales, 5th Edition (SB-5);
  • written consent by parents.

Exclusion

  • SNAP IV score \<1;
  • not taking ADHD medications in the past 2-4 weeks;
  • treated with TMS/rTMS/tDCS or electroconvulsive therapy in the past 12 months;
  • taking monoamine oxidase inhibitors in the past 14 days;
  • have a history of epilepsy, brain trauma, brain surgery/brain tumour, brain aneurysm or other concomitant unstable major medical conditions like haemophilia or other blood clotting disorders or thrombosis;
  • significant communicative impairments;
  • having metal implants in the brain treatment region /artificial cardiac pacemaker in-situ;
  • taking corticosteroid treatment within the last six weeks before the first TPS treatment;
  • have a history of micro-cavernomas.

Key Trial Info

Start Date :

June 1 2022

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

January 13 2023

Estimated Enrollment :

32 Patients enrolled

Trial Details

Trial ID

NCT05422274

Start Date

June 1 2022

End Date

January 13 2023

Last Update

March 13 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

School of Nursing HongKongPolyU

Hong Kong, Hong Kong